Daily development photo and survival of <i>in vitro</i> reared honey bee drones. by Marina Carla Bezerra da Silva (19336849)

Subjects:

Dataset of adult honey bee drone abdominal area reared <i>in vitro</i>. by Marina Carla Bezerra da Silva (19336849)

Subjects:

Data for ventilation characterization of Room A. by Farideh Hosseini Narouei (22032798)

Subjects:

Bleeding on Marginal Probing (BOMP) scores in the test and control groups at baseline and after 8 weeks. by Flavia Furlaneto (20161022)

Subjects:

Honey bee drones reared <i>in vitro</i> from four days after queen caging. by Marina Carla Bezerra da Silva (19336849)

Subjects:

<i>In vitro</i> rearing protocol for honey bee (<i>Apis mellifera</i>) drones. by Marina Carla Bezerra da Silva (19336849)

Subjects:

Supplementary Material for: Efficacy of combined herbal and Western medicine based on Traditional Chinese Medicine for mild cognitive impairment and dementia in Parkinson’s disease... by figshare admin karger (2628495)

“…Two authors independently screened and selected studies and extracted data related to trial quality, characteristics, and results. …”

Table 1_Efgartigimod for the treatment of immune checkpoint inhibitor-associated myocarditis complicated with impending crisis state of myasthenia gravis: a case report.docx by Mingjia Lu (21593324)

“…Treatment with efgartigimod (10 mg/kg) significantly improved myasthenic symptoms, with Myasthenia Gravis–Activities of Daily Living (MG-ADL) and Quantitative Myasthenia Gravis (QMG) scores decreasing from 11 to 5 and 26 to 11, respectively. …”

Data Sheet 1_Efgartigimod for the treatment of immune checkpoint inhibitor-associated myocarditis complicated with impending crisis state of myasthenia gravis: a case report.pdf by Mingjia Lu (21593324)

“…Treatment with efgartigimod (10 mg/kg) significantly improved myasthenic symptoms, with Myasthenia Gravis–Activities of Daily Living (MG-ADL) and Quantitative Myasthenia Gravis (QMG) scores decreasing from 11 to 5 and 26 to 11, respectively. …”

Table 2_Efgartigimod for the treatment of immune checkpoint inhibitor-associated myocarditis complicated with impending crisis state of myasthenia gravis: a case report.docx by Mingjia Lu (21593324)

“…Treatment with efgartigimod (10 mg/kg) significantly improved myasthenic symptoms, with Myasthenia Gravis–Activities of Daily Living (MG-ADL) and Quantitative Myasthenia Gravis (QMG) scores decreasing from 11 to 5 and 26 to 11, respectively. …”

Table 3_Efgartigimod for the treatment of immune checkpoint inhibitor-associated myocarditis complicated with impending crisis state of myasthenia gravis: a case report.docx by Mingjia Lu (21593324)

“…Treatment with efgartigimod (10 mg/kg) significantly improved myasthenic symptoms, with Myasthenia Gravis–Activities of Daily Living (MG-ADL) and Quantitative Myasthenia Gravis (QMG) scores decreasing from 11 to 5 and 26 to 11, respectively. …”

Data Sheet 2_The effect of training intervention based on health belief model on self-care behaviors of women with gestational diabetes mellitus.pdf by Fatemeh Mohammadkhah (14157844)

“…Also, the comparison of averages of blood sugar levels after the intervention in the two groups indicated that fasting blood sugar level, A1C hemoglobin, and blood sugar levels measured 2 h after the meal significantly decreased in the intervention group (p < 0.001). …”

Data Sheet 1_The effect of training intervention based on health belief model on self-care behaviors of women with gestational diabetes mellitus.pdf by Fatemeh Mohammadkhah (14157844)

“…Also, the comparison of averages of blood sugar levels after the intervention in the two groups indicated that fasting blood sugar level, A1C hemoglobin, and blood sugar levels measured 2 h after the meal significantly decreased in the intervention group (p < 0.001). …”

Table 6_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx by Baodong Wang (3359171)

“…However, regions with high smoking rates and low socio-economic status still face a significant burden from smoking-related LBP. The data from these regions highlight the need for targeted health policies and interventions to further reduce the burden of smoking-related LBP.…”

Table 4_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx by Baodong Wang (3359171)

“…However, regions with high smoking rates and low socio-economic status still face a significant burden from smoking-related LBP. The data from these regions highlight the need for targeted health policies and interventions to further reduce the burden of smoking-related LBP.…”

Table 5_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx by Baodong Wang (3359171)

“…However, regions with high smoking rates and low socio-economic status still face a significant burden from smoking-related LBP. The data from these regions highlight the need for targeted health policies and interventions to further reduce the burden of smoking-related LBP.…”

Table 3_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx by Baodong Wang (3359171)

“…However, regions with high smoking rates and low socio-economic status still face a significant burden from smoking-related LBP. The data from these regions highlight the need for targeted health policies and interventions to further reduce the burden of smoking-related LBP.…”

Table 7_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx by Baodong Wang (3359171)

“…However, regions with high smoking rates and low socio-economic status still face a significant burden from smoking-related LBP. The data from these regions highlight the need for targeted health policies and interventions to further reduce the burden of smoking-related LBP.…”

Table 2_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xls by Baodong Wang (3359171)

“…However, regions with high smoking rates and low socio-economic status still face a significant burden from smoking-related LBP. The data from these regions highlight the need for targeted health policies and interventions to further reduce the burden of smoking-related LBP.…”

Image 1_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.tif by Baodong Wang (3359171)

“…However, regions with high smoking rates and low socio-economic status still face a significant burden from smoking-related LBP. The data from these regions highlight the need for targeted health policies and interventions to further reduce the burden of smoking-related LBP.…”